Nabriva Therapeutics plc

NasdaqCM:NBRV Stock Report

Mkt Cap: US$4.9m

Nabriva Therapeutics Future Growth

How is Nabriva Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


60.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqCM:NBRV - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202513416N/AN/A1
12/31/2024104-4N/AN/A1
12/31/202368-32N/AN/A2
9/30/202236-47-41-41N/A
6/30/202235-47-48-48N/A
3/31/202234-47-54-54N/A
12/31/202129-49-60-60N/A
9/30/202122-54-67-67N/A
6/30/202115-57-66-66N/A
3/31/20217-60-65-65N/A
12/31/20205-69-71-71N/A
9/30/20203-75-74-73N/A
6/30/20209-80-76-76N/A
3/31/20209-86-79-79N/A
12/31/20199-83-72-72N/A
9/30/201910-91-79-79N/A
6/30/20193-126-81-81N/A
3/31/20194-122-77-77N/A
12/31/201810-115-73-73N/A
9/30/201810-106-75-75N/A
6/30/201811-76-74-72N/A
3/31/201811-72-72-71N/A
12/31/20175-74-71-69N/A
9/30/20177-67-57-56N/A
6/30/20176-59-54-53N/A
3/31/20177-57-53-52N/A
12/31/20166-55-49-48N/A
9/30/20165-67-42-41N/A
6/30/20165-61N/AN/AN/A
3/31/20165-55N/A-30N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NBRV is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: NBRV is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: NBRV is expected to become profitable in the next 3 years.

Revenue vs Market: NBRV's revenue (29% per year) is forecast to grow faster than the US market (7% per year).

High Growth Revenue: NBRV's revenue (29% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if NBRV's Return on Equity is forecast to be high in 3 years time


Discover growth companies